Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy.

PLoS One · 2013 · PMC3716693 · PMID 23894329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

As summarized in Figure 4 (A, C), the cell viability of PEG-Bu, PEI-Bu and PEI 25 kDa displayed a decreasing trend with increasing polymer concentration, indicating that the cytotoxicity of these polymers was concentration-dependent.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.